Sum of the longest diameters of metastatic liver tumors is a possible new prognostic factor after hepatectomy in patients with colorectal liver metastases

Hepato-Gastroenterology

Volumn 53, Issue 72, 2006, Pages 909-912

  Eto, Tada Aki ^a   Chijiiwa, Kazuo ^a   Hidaka, Hideki ^a   Ohuchida, Jiro ^a   Kai, Masa Hiro ^a   Kondo, Kazuhiro ^a   Hotokezaka, Masayuki ^a  

^a UNIVERSITY OF MIYAZAKI   (Japan)

Author keywords

Colorectal liver metastasis; Prognostic factor; Sum of longest diameter

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; CISPLATIN; FLUOROURACIL;

ADULT; AGED; ARTICLE; BLOOD VESSEL PERMEABILITY; CANCER STAGING; CANCER SURVIVAL; COLORECTAL TUMOR; CONTROLLED STUDY; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER METASTASIS; LIVER RESECTION; LIVER TUMOR; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; PRIORITY JOURNAL; PROGNOSIS; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; FEMALE; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; TREATMENT OUTCOME;

EID: 33845192035     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Minagawa M, Makuuehi M, Torzilli G, et al: Extension of the frontiers of surgical indications in the treatment of liver metastases from colorectal cancer: long-term results. Ann Surg 2000; 231:487-499.
2. Primrose JN: Treatment of colorectal metastases: surgery, cryotherapy, or radiofrequency ablation. Gut 2002; 50:1-5.
3. Seifert JK, Morris DL: Indicators of recurrence following cryotherapy for hepatic metastases from colorectal cancer. Br J Surg 1999; 86:234-240.
4. Ueno H, Mochizuki H, Hatsuse K, et al: Indicators for treatment strategies of colorectal liver metastases. Ann Surg 2000; 231:59-66.
5. Takahashi S, Inoue K, Konishi M, et al: Prognostic factors for poor survival after repeat hepatectomy in patients with colorectal liver metastases. Surgery 2003; 133:627-634.
6. Weber JC, Nakano H, Bachellier P, et al: Is a proliferation index of cancer cells a reliable prognostic factor after hepatectomy in patients with colorectal liver metastases? Am J Surg 2001; 182:81-88.
7. Ferrero A, Polastri R, Muratore A, et al: Extensive resections for colorectal liver metastases. J Hepatobiliary Pancreat Surg 2004; 11:92-96.
8. King J, Caplehorn JR, Ross WB, Morris DL: High serum carcinoembryonic antigen concentration in patients with colorectal liver metastases is associated with poor cell-mediated immunity, which is predictive of survival. Br J Surg 1997; 84:1382-1385.
9. Nagashima I, Takada T, Matsuda K, et al: A new scoring system to classify patients with colorectal liver metastases: proposal of criteria to select candidates for hepatic resection. J Hepatobiliary Pancreat Surg 2004; 11:79-83.
10. Ueno H, Mochizuki H, Hashiguchi Y, et al: Predictors of extrahepatic recurrence after resection of colorectal liver metastases. Br J Surg 2004; 91:327-333.
11. Fong Y, Fortner J, Sun RL, et al: Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg 1999; 230:309-321.
12. Japanese Society for Cancer of the Colon and Rectum: Japanese Classification of Colorectal Carcinoma. First English Edition: Kanehara & Co., Ltd., Tokyo, Japan, 1997.
13. Therasse P, Arbuck SG, Eisenhauer EA, et al: New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 2000; 92:205-216.